Market Closed -
OTC Markets
03:33:15 2024-07-12 pm EDT
|
5-day change
|
1st Jan Change
|
0.00075
USD
|
-10.71%
|
|
-20.00%
|
-93.33%
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
-
|
-
|
0.1833
|
0.641
|
0.5477
|
0.5585
|
Enterprise Value (EV)
1 |
-
|
-
|
1.75
|
1.319
|
1.642
|
1.094
|
P/E ratio
|
-
|
-
|
-
|
-
|
-0.07
x
|
-0.08
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / Revenue
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / EBITDA
|
-
|
-
|
-0.5
x
|
-0.73
x
|
-0.83
x
|
-0.62
x
|
EV / FCF
|
-
|
-
|
-1.08
x
|
-1.7
x
|
-1.05
x
|
-2.16
x
|
FCF Yield
|
-
|
-
|
-92.3%
|
-58.7%
|
-95%
|
-46.4%
|
Price to Book
|
-
|
-
|
-
|
-0.24
x
|
-0.27
x
|
-0.26
x
|
Nbr of stocks (in thousands)
|
-
|
-
|
0.05
|
12.4
|
149
|
4,137
|
Reference price
2 |
27,500,000
|
6,000,000
|
3,900
|
51.70
|
3.675
|
0.1350
|
Announcement Date
|
9/17/18
|
10/15/19
|
10/1/20
|
9/28/21
|
9/28/22
|
9/28/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-3.958
|
-2.612
|
-3.492
|
-1.81
|
-1.989
|
-1.775
|
EBIT
1 |
-3.96
|
-2.615
|
-3.494
|
-1.812
|
-1.991
|
-1.777
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-7.218
|
-5.874
|
-4.875
|
-2.139
|
-2.713
|
-2.79
|
Net income
1 |
-7.039
|
-5.758
|
-4.741
|
-2.026
|
-2.658
|
-2.661
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-49.23
|
-1.798
|
Free Cash Flow
1 |
-2.673
|
-1.243
|
-1.615
|
-0.7744
|
-1.559
|
-0.5074
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/17/18
|
10/15/19
|
10/1/20
|
9/28/21
|
9/28/22
|
9/28/23
|
Fiscal Period: June |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
4.73
|
1.74
|
1.57
|
0.68
|
1.09
|
0.54
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-1.196
x
|
-0.6653
x
|
-0.4487
x
|
-0.3745
x
|
-0.5502
x
|
-0.3019
x
|
Free Cash Flow
1 |
-2.67
|
-1.24
|
-1.61
|
-0.77
|
-1.56
|
-0.51
|
ROE (net income / shareholders' equity)
|
115%
|
104%
|
119%
|
60.4%
|
87.3%
|
86.7%
|
ROA (Net income/ Total Assets)
|
-2,974%
|
-1,889%
|
-2,182%
|
-2,029%
|
-2,626%
|
-1,564%
|
Assets
1 |
0.2367
|
0.3049
|
0.2173
|
0.0998
|
0.1012
|
0.1701
|
Book Value Per Share
|
-
|
-
|
-
|
-219.0
|
-13.70
|
-0.5200
|
Cash Flow per Share
|
-
|
-
|
-
|
0.1600
|
0.0200
|
0
|
Capex
|
-
|
0
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
9/17/18
|
10/15/19
|
10/1/20
|
9/28/21
|
9/28/22
|
9/28/23
|
|
1st Jan change
|
Capi.
|
---|
| -93.33% | 137K | | +20.12% | 126B | | +25.25% | 119B | | +25.56% | 27.95B | | -19.51% | 20.5B | | -14.36% | 17.12B | | -15.63% | 16.1B | | -46.67% | 14.97B | | +11.89% | 14.84B | | +57.74% | 14.38B |
Bio Therapeutic Drugs
|